Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer

Breast Cancer Research and Treatment

Volumn 74, Issue 2, 2002, Pages 101-111

  Skånberg, Jan ^a   Ahlman, Håkan ^a   Benjegård, Sven Anders ^a   Fjälling, Martha ^a   Forssell Aronsson, Eva B ^a   Hashemi, Sayed Hossein ^a   Nilsson, Ola ^a   Suurkula, Madis ^a   Jansson, Svante ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

111In; Breast cancer; Octreotide; Scintigraphy; Somatostatin receptors

Indexed keywords

ESTROGEN RECEPTOR; INDIUM 111; PENTETREOTIDE IN 111; PROGESTERONE RECEPTOR; SOMATOSTATIN RECEPTOR; DIAGNOSTIC AGENT; HORMONE; INDIUM; OCTREOTIDE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CALCULATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MEASUREMENT; NORTHERN BLOTTING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOACTIVITY; RIBONUCLEASE PROTECTION ASSAY; SCINTIMAMMOGRAPHY; SCINTISCANNING; TUMOR BIOPSY; TUMOR VOLUME; BIOPSY; BIOSYNTHESIS; BREAST TUMOR; CANCER INVASION; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; FEMALE; HORMONES, SYNTHETIC; HUMAN; IMMUNOHISTOCHEMISTRY; INDIUM RADIOISOTOPES; LYMPHATIC METASTASIS; MIDDLE AGE; NEOPLASM INVASIVENESS; OCTREOTIDE; RADIONUCLIDE IMAGING; RECEPTORS, SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; HORMONES; HUMANS; MIDDLE AGED;

EID: 0035990727     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016120529858     Document Type: Article

References (44)

1. Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro
2. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro
3. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice
4. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
5. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase
6. Cloning and characterization of a fourth human somatostatin receptor
7. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
8. Molecular pharmacology of somatostatin-receptor subtypes
9. Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I
10. Somatostatin analogs: Angiogenesis inhibitors with novel mechanisms of action
11. Somatostatin receptor imaging in patients with neuroendocrine tumors: Preoperative and post-operative scintigraphy and intraoperative use of a scintillation detector
12. Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection
13. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma
14. Somatostatin receptor scintigraphy in medullary thyroid carcinoma
15. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors
16. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide
17. Intraoperative gamma probe detection of neuroendocrine tumors
18. Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome
19. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells
20. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells
21. Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: A randomized study with long-term follow-up
22. Somatostatin-receptor scintigraphy in primary breast cancer
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors
25. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
26. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to EGF receptors
27. Receptors for somatostatin and somatostatin analogues in human breast tumors
28. Dynamic indium-111-pentetreotide scintigraphy in breast cancer
29. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization
30. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels
31. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2
32. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma
33. Analysis of somatostatin receptor subtype mRNA expression in human breast cancer
34. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines
35. Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide
36. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells
37. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases
38. Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: Preliminary results
39. Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography
40. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
41. Radioguided sentinel node biopsy to avoid axillary dissection in breast cancer
42. Somatostatin receptors on neuroendocrine tumors - A way to intraoperative diagnosis and localization
43. Enhancement of the anti-neoplastic effects of tamoxifen by somatostatin analogues
44. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver